Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-28

FDA Approved: CABERGOLINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for cabergoline.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CABERGOLINE (CABERGOLINE)

Snippet

SUPPL AP for CABERGOLINE (CABERGOLINE)